Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 215, Issue 5, Pages 703-712Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiw632
Keywords
bacteriophage; phage therapy; endocarditis; Pseudomonas aeruginosa; resistance; antibiotic
Categories
Funding
- Swiss National Research Foundation [CR31I3_166124, 310030-143799]
- European Commission
- Loterie Suisse Romande
- Swiss National Science Foundation (SNF) [CR31I3_166124, 310030_143799] Funding Source: Swiss National Science Foundation (SNF)
Ask authors/readers for more resources
Background. Increasing antibiotic resistance warrants therapeutic alternatives. Here we investigated the efficacy of bacterio-phage-therapy (phage) alone or combined with antibiotics against experimental endocarditis (EE) due to Pseudomonas aeruginosa, an archetype of difficult-to-treat infection. Methods. In vitro fibrin clots and rats with aortic EE were treated with an antipseudomonas phage cocktail alone or combined with ciprofloxacin. Phage pharmacology, therapeutic efficacy, and resistance were determined. Results. In vitro, single-dose phage therapy killed 7 log colony-forming units (CFUs)/g of fibrin clots in 6 hours. Phage-resistant mutants regrew after 24 hours but were prevented by combination with ciprofloxacin (2.5 x minimum inhibitory concentration). In vivo, single-dose phage therapy killed 2.5 log CFUs/g of vegetations in 6 hours (P < .001 vs untreated controls) and was comparable with ciprofloxacin monotherapy. Moreover, phage/ciprofloxacin combinations were highly synergistic, killing >6 log CFUs/g of vegetations in 6 hours and successfully treating 64% (n = 7/11) of rats. Phage-resistant mutants emerged in vitro but not in vivo, most likely because resistant mutations affected bacterial surface determinants important for infectivity (eg, the pilT and galU genes involved in pilus motility and LPS formation). Conclusions. Single-dose phage therapy was active against P. aeruginosa EE and highly synergistic with ciprofloxacin. Phage-resistant mutants had impaired infectivity. Phage-therapy alone or combined with antibiotics merits further clinical consideration.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available